Annual report
3750.TEDINET S100R3DH
Period2022-04-01 → 2023-03-31
Filed2023-06-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amended by S100RDHU (2023-07-11). Amended by S100RS4G (2023-08-30).
Key figures · 147
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥1.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥1.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | −¥794m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | −¥462m | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | −¥862m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥418m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥746m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥185m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥204m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥65m | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥78m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥832m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥319m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥593m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | −¥77m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥14.1bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥16.0bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥14.9bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥15.5bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥7.5bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥11.4bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥12.3bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.7bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.7bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.5bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥3.8bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥3.6bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥852m | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥673m | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥702m | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1000m | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.5bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥40m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥188m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥83m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥532m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥2.8bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥283m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥216m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥7m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥1.4bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥294m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥36m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥151m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-118.71 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.79 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-101.64 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.58 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥88.3 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥273.41 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥392.12 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥381.28 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥568.06 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥536.39 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 17.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.3% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.6% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.1% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | -35.6% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -2.3% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -23.3% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.6% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.8% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 64 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 63 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 51 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 53 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 5 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥465m | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥153m | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥142m | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥235m | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥221m | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | −¥4m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥4m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | −¥196m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥212m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥93m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥451m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥663m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥814m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥256m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | −¥737m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥270m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥8m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥544m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.2bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥11.9bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥13.0bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥12.8bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥9.8bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥3.6bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.0bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.3bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥7.0bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.7bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.2bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥3.9bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥3.5bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥466m | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥206m | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-82.54 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.61 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.97 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.01 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥177.38 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥30.39 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥0.96 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥10 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥778.7 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥861.25 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥823.29 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥587.5 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥526.51 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 56.5% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.7% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 99.0% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -10.4% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.2% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 40.1% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 8,929,419 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,929,419 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,711,419 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,183,195 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,183,195 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 6 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 5 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 5 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 5 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 4 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥625,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-03-31 | ¥635m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2023-03-31 | −¥161m |
| Medical Asset Managemetreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥54m |
| Medical Asset Managemetreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥15m |
| Medical Asset Managemetreportable segment | employees | at 2023-03-31 | 11 pure |
| Medical Asset Managemetreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥238m |
| Medical Asset Managemetreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥238m |
| Medical Asset Managemetreportable segment | segment assets | at 2023-03-31 | ¥455m |
| Medical Asset Managemetreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥403m |
| Real Asset Managementreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥110m |
| Real Asset Managementreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥270m |
| Real Asset Managementreportable segment | employees | at 2023-03-31 | 48 pure |
| Real Asset Managementreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| Real Asset Managementreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| Real Asset Managementreportable segment | segment assets | at 2023-03-31 | ¥13.0bn |
| Real Asset Managementreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥230m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥164m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥285m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥2.1bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥2.1bn |
| —segment total | segment assets | at 2023-03-31 | ¥13.5bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | −¥633m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2021-04-01 → 2022-03-31 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2022-03-31 | ¥308m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2022-03-31 | −¥148m |
| Medical Asset Managemetreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥26m |
| Medical Asset Managemetreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥16m |
| Medical Asset Managemetreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥257m |
| Medical Asset Managemetreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥257m |
| Medical Asset Managemetreportable segment | segment assets | at 2022-03-31 | ¥528m |
| Medical Asset Managemetreportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥158m |
| Real Asset Managementreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥155m |
| Real Asset Managementreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥257m |
| Real Asset Managementreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.1bn |
| Real Asset Managementreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.1bn |
| Real Asset Managementreportable segment | segment assets | at 2022-03-31 | ¥15.2bn |
| Real Asset Managementreportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥157m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥182m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥273m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥1.3bn |
| —segment total | segment assets | at 2022-03-31 | ¥15.7bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | −¥314m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,271
| Item | Context | Value | Unit |
|---|---|---|---|
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember_LegalRetainedEarningsMember | - | JPY |
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember_RetainedEarningsBroughtForwardMember | -736992000 | JPY |
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember_RetainedEarningsMember | -736992000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_CapitalStockMember | 100000000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_LegalCapitalSurplusMember | 2445118000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_OtherCapitalSurplusMember | 3122846000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_CapitalSurplusMember | 5567965000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_LegalRetainedEarningsMember | 18286000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_RetainedEarningsBroughtForwardMember | 1056137000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_RetainedEarningsMember | 1074424000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember_TreasuryStockMember | -982000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember_ShareholdersEquityMember | 7478399000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember_SubscriptionRightsToSharesMember | 211501000 | JPY |
| Net assets | Prior1YearInstant_NonConsolidatedMember | 7689900000 | JPY |
| Profit loss | CurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember | -736992000 | JPY |
| Profit loss | CurrentYearDuration_NonConsolidatedMember | -736992000 | JPY |
| Purchase of treasury stock | CurrentYearDuration_NonConsolidatedMember_TreasuryStockMember | -257000 | JPY |
| Purchase of treasury stock | CurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember | -257000 | JPY |
| Purchase of treasury stock | CurrentYearDuration_NonConsolidatedMember | -257000 | JPY |
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember_TreasuryStockMember | -257000 | JPY |
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember | -737250000 | JPY |
| Total changes of items during the period | CurrentYearDuration_NonConsolidatedMember | -737250000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_TreasuryStockMember | -1240000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_ShareholdersEquityMember | 6741149000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember_SubscriptionRightsToSharesMember | 211501000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember | 6952650000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)有価証券報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第1項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-06-23 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第19期(自 2022年4月1日 至 2023年3月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社サイトリ細胞研究所(旧会社名 FRACTALE株式会社) | |
| Company name in english cover page | FilingDateInstant | Text · Plus | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 星野 喜宏 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都千代田区大手町一丁目1番1号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03-6860-5701 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役経営企画部長 藤村 剛 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都千代田区大手町一丁目1番1号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 03-6860-5701 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役経営企画部長 藤村 剛 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Footnotes cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E05443 | |
| Fund code | FilingDateInstant | - | |
| Security code | FilingDateInstant | 37500 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社サイトリ細胞研究所 | |
| Filer name in english | FilingDateInstant | Cytori Cell Research Institute,Inc. | |
| Fund name in japanese | FilingDateInstant | - | |
| Fund name in english | FilingDateInstant | - | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |